| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 12/12/2007 | EP1863530A1 Methods for damaging cells using effector functions of anti-gfra1 antibodies |
| 12/12/2007 | EP1863529A1 Novel composition |
| 12/12/2007 | EP1863528A2 Use of wnv dna vaccine in combination with a conventional vaccine to overcome immunogen interference |
| 12/12/2007 | EP1863527A2 Mannose immunogens for hiv-1 |
| 12/12/2007 | EP1863526A1 Live attenuated rotavirus vaccine for oral administration |
| 12/12/2007 | EP1863525A2 Polypeptides |
| 12/12/2007 | EP1863520A1 Use of interleukin 17e for the treatment of cancer |
| 12/12/2007 | EP1863340A2 Gene disruptions, compositions and methods relating thereto |
| 12/12/2007 | EP1622642B1 Avian e. coli vaccine for the protection against colibacillosis |
| 12/12/2007 | EP1355668B1 Use of il-18 inhibitors for the treatment and/or prevention of heart disease |
| 12/12/2007 | EP1237912B1 Five-helix protein |
| 12/12/2007 | EP1180119B1 Recombinant haemophilus influenzae adhesin proteins |
| 12/12/2007 | EP1148779B1 Expression of secreted human alpha-fetoprotein in transgenic animals |
| 12/12/2007 | EP1137792B9 A recombinant vector expressing multiple costimulatory molecules and uses thereof |
| 12/12/2007 | EP1000144B1 Lactoferrin receptor gene of moraxella |
| 12/12/2007 | EP0894130B1 Modulators of tnf receptor associated factor (traf), their preparation and use |
| 12/12/2007 | EP0888377B1 MURINE alpha(1,3)-FUCOSYLTRANSFERASE (Fuc-TVII) |
| 12/12/2007 | EP0841942B2 Method for industrially producing a japanese encephalitis vaccine, and resulting vaccine |
| 12/12/2007 | EP0647140B1 Papillomavirus vaccines |
| 12/12/2007 | CN101087808A Compositions of influenza viral proteins and methods of use thereof |
| 12/12/2007 | CN101087806A Immunoglobulins comprising predominantly a Ga1GlcNAcMan5GLcNAc2 glycoform |
| 12/12/2007 | CN101087803A Pasteurella multocida vaccine |
| 12/12/2007 | CN101087620A Vaccine and nucleic acids capable of protecting poultry against colonisation by campylobacter |
| 12/12/2007 | CN101085811A SARS coronavirus pharmaceutical target and application thereof |
| 12/12/2007 | CN101085349A Vesicle guiding immunocyte and application of the same in preparing antineoplastic medicine |
| 12/12/2007 | CN101085348A Nasal cavity immunity composite adjuvant for avian influenza inactivation antigen |
| 12/12/2007 | CN101085347A Hepatitis A, hepatitis B and hepatitis E combination vaccine |
| 12/12/2007 | CN101085346A Attenuated pestiviruses |
| 12/12/2007 | CN101084923A Method for preparing rabbit against human T lymphocytes immune serum |
| 12/12/2007 | CN100354431C Method of PCR testing of pooled blood samples |
| 12/12/2007 | CN100354425C Production of attenuated, human-bovine chimeric respiratory syncytial virus vaccines |
| 12/12/2007 | CN100354414C Pseudo-rabies gE/gI-gene loss poison strain, killed vaccine containing it and use |
| 12/12/2007 | CN100354307C NOGO receptor-mediated blockade of axonal growth |
| 12/12/2007 | CN100354297C Adjuvanted meningococcus compositions |
| 12/12/2007 | CN100354004C Tubercle bacillus chimeric gene vaccine and preparation process thereof |
| 12/12/2007 | CN100354002C New type of cell vaccine with heteroimmune cell as cell vector and its prepn process |
| 12/12/2007 | CN100353997C Stabilized preparation containing protein |
| 12/11/2007 | US7307154 DNA encoding a novel RG1 polypeptide |
| 12/11/2007 | US7307153 Antibodies that bind PRO9912 |
| 12/11/2007 | US7307101 Administering N-hydroxy-N-(4-butyl-2-methylphenyl)-formamidine (HET0016) to increase or prevent a decrease in cerebral blood flow |
| 12/11/2007 | US7307068 Use of rapamycin to inhibit immune response and induce tolerance to gene therapy vector and encoded transgene products |
| 12/11/2007 | US7307066 Hepatitis C virus codon optimized non-structural NS3/4A fusion gene |
| 12/11/2007 | US7307064 Methods for treating cardiovascular disease using a soluble CTLA4 molecule |
| 12/11/2007 | US7306945 Fragment of alpha-synuclein is contacted with a drug; reduction in the rate or extent of aggregation fragment of alpha-synuclein relative to a control lacking the agent indicates the agent has the pharmacological activity |
| 12/11/2007 | US7306927 Diagnosing cancer in humans; obtain sample, detect expression of chymotrypsin, presence of chymotrypsin enzyme indicates cancer |
| 12/11/2007 | US7306920 Gene associated with regulation of energy balance, obesity and diabetes and uses therefor |
| 12/11/2007 | US7306907 Single domain ligands, receptors comprising said ligands, methods for their production, and use of said ligands and receptors |
| 12/11/2007 | US7306901 Methods and means for assessing HIV envelope inhibitor therapy |
| 12/11/2007 | US7306808 Orientia tsutsugamushi truncated recombinant outer membrane protein (r47) and (r57) vaccines diagnostics and therapeutics for scrub typhus |
| 12/11/2007 | US7306807 Immunize cats, veterinary medicine |
| 12/11/2007 | US7306806 Recombinant P. falciparum merozoite protein-142 vaccine |
| 12/11/2007 | US7306805 Nontypeable Haemophilus influenzae virulence factors |
| 12/11/2007 | US7306804 HIV-specific T-cell induction |
| 12/11/2007 | US7306803 Methods for modulating angiogenesis |
| 12/11/2007 | US7306801 Methods of therapy for cancers characterized by overexpression of the HER2 receptor protein |
| 12/11/2007 | US7306800 Monoclonal antibody that recognizes a human 8F4 polypeptide, wherein 8F4 polypeptide: is an inducible T cell costimulatory molecule; occurs on two-signal-activated CD4+ T lymphocytes from human peripheral blood; dimer of two peptide chains |
| 12/11/2007 | US7306799 Use of fusion polypeptides capable of binding vascular endothelial cell growth factor (VEGF), VEGF family members, and splice variants with specifically desirable characteristics; therapy for ocular diseases |
| 12/11/2007 | US7306798 For AIDS and as a diagnostic tool or as a preventative and curative medicament; selectively binds the R7V epitope of the gp160 protein of the HIV-1 virus |
| 12/11/2007 | US7306797 Use of a compound antagonist of ESM-1 protein for producing a medicine for treating cancer |
| 12/11/2007 | US7306796 13-transmembrane protein expressed in prostate cancer |
| 12/11/2007 | US7306795 PRO5774 antibodies |
| 12/11/2007 | US7306792 In particular, invention relates to alphavirus-based, preferably Sindbis virus-based, vectors and to non-alphavirus-based vectors, which have a preferential affinity for high affinity laminin receptors |
| 12/11/2007 | US7306782 Method for the production of conjugates and uses thereof for the prevention and treatment of allergic reactions and autoimmune diseases |
| 12/11/2007 | CA2259141C Treatment and diagnosis of infections of gram positive cocci |
| 12/11/2007 | CA2171618C Purine nucleoside phosphorylase gene therapy for human malignancy |
| 12/06/2007 | WO2007140410A2 Low-density lipoprotein receptor 6 (lrp6) as a mammary stem cell marker and related methods |
| 12/06/2007 | WO2007140282A1 Peg linker compounds and biologically active conjugates thereof |
| 12/06/2007 | WO2007140249A1 Methods of treating stroke |
| 12/06/2007 | WO2007140244A2 Vaccination of young animals against lawsonia intracellularis infections |
| 12/06/2007 | WO2007140205A2 Methods of treating fibrosis |
| 12/06/2007 | WO2007140061A2 A method for determining and predicting protein autonomous folding |
| 12/06/2007 | WO2007139821A2 Methods of using lrr superfamily genes and proteins |
| 12/06/2007 | WO2007139208A1 Pharmaceutical composition for prevention or treatment of disease associated with platelet adhesion/aggregation reaction, and method for screening for the same |
| 12/06/2007 | WO2007139190A1 Immunostimulatory oligonucleotide and pharmaceutical application thereof |
| 12/06/2007 | WO2007139164A1 Humanized anti-human osteopontin antibody |
| 12/06/2007 | WO2007139150A1 ANTI-INFLUENZA VIRAL AGENT COMPRISING TNF-α INHIBITOR |
| 12/06/2007 | WO2007138339A2 Treatment of pain by use of a single chain polypeptide fusion protein |
| 12/06/2007 | WO2007138155A1 Improved expression of tuberculosis vaccine proteins in plants |
| 12/06/2007 | WO2007138036A1 Vaccine against rickettsia-like organisms |
| 12/06/2007 | WO2007137986A2 Vaccination against cancer |
| 12/06/2007 | WO2007137984A2 Modified humanised anti-interleukin-18 antibodies |
| 12/06/2007 | WO2007137847A1 Process for production of a vaccine composition |
| 12/06/2007 | WO2007137846A1 Process for production of a vaccine composition |
| 12/06/2007 | WO2007137591A2 Hiv vaccine |
| 12/06/2007 | WO2007137586A2 Random insertion of peptides |
| 12/06/2007 | WO2007137427A1 Bioactive purified hspe7 compositions |
| 12/06/2007 | WO2007137342A1 Methods of modulating epithelial-mesenchymal transition and mesenchymal-epithelial transition in cells and agents useful for the same |
| 12/06/2007 | WO2007120170A9 Compositions and methods for treating gram positive bacterial infection in a mammalian subject |
| 12/06/2007 | WO2007118986A3 Concentrate of immunoglobulins and f(ab)'2 and/or fab fragments specific of an arbovirus as medicine |
| 12/06/2007 | WO2007113598A3 Peptide mimetope vaccine of- and antibodies against 6b pneumococcal polysaccharides |
| 12/06/2007 | WO2007109221A9 Methods for reducing protein aggregation |
| 12/06/2007 | WO2007084633A3 Viable non-toxic gram negative bacteria |
| 12/06/2007 | WO2007080174A3 Chimeric and humanised anti-human il-13 antibodies |
| 12/06/2007 | WO2007062245A3 Human monoclonal antibody human cd134 (ox40) and methods of making and using same |
| 12/06/2007 | WO2007055704A3 Immunostimulatory properties of oligonucleotide-based compounds comprising modified immunostimulatory dinucleotides |
| 12/06/2007 | WO2007053188A3 Production of multivalent virus like particles |
| 12/06/2007 | WO2007044382A3 Proteins with improved solubility and methods for producing and using same |
| 12/06/2007 | WO2007034489A3 Immunogenic fragments of t-cell receptor constant domains and peptides derived therefrom |
| 12/06/2007 | WO2007027742A3 SMALL MOLECULE INTEGRIN α2βl/GPIa-IIa ANTAGONISTS |
| 12/06/2007 | WO2006138181A3 Self-buffering protein formulations |